Literature DB >> 25401477

Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.

Yassine Sassi, Andrea Ahles, Dong-Jiunn Jeffery Truong, Younis Baqi, Sang-Yong Lee, Britta Husse, Jean-Sébastien Hulot, Ariana Foinquinos, Thomas Thum, Christa E Müller, Andreas Dendorfer, Bernhard Laggerbauer, Stefan Engelhardt.   

Abstract

Acute stimulation of cardiac β-adrenoceptors is crucial to increasing cardiac function under stress; however, sustained β-adrenergic stimulation has been implicated in pathological myocardial remodeling and heart failure. Here, we have demonstrated that export of cAMP from cardiac myocytes is an intrinsic cardioprotective mechanism in response to cardiac stress. We report that infusion of cAMP into mice averted myocardial hypertrophy and fibrosis in a disease model of cardiac pressure overload. The protective effect of exogenous cAMP required adenosine receptor signaling. This observation led to the identification of a potent paracrine mechanism that is dependent on secreted cAMP. Specifically, FRET-based imaging of cAMP formation in primary cells and in myocardial tissue from murine hearts revealed that cardiomyocytes depend on the transporter ABCC4 to export cAMP as an extracellular signal. Extracellular cAMP, through its metabolite adenosine, reduced cardiomyocyte cAMP formation and hypertrophy by activating A1 adenosine receptors while delivering an antifibrotic signal to cardiac fibroblasts by A2 adenosine receptor activation. Together, our data reveal a paracrine role for secreted cAMP in intercellular signaling in the myocardium, and we postulate that secreted cAMP may also constitute an important signal in other tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25401477      PMCID: PMC4297204          DOI: 10.1172/JCI74349

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  Beta-adrenergic receptor desensitization in cardiac hypertrophy and heart failure.

Authors:  D J Choi; H A Rockman
Journal:  Cell Biochem Biophys       Date:  1999       Impact factor: 2.194

Review 2.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 3.  Attenuating myocardial ischemia by targeting A2B adenosine receptors.

Authors:  Holger K Eltzschig; Stephanie K Bonney; Tobias Eckle
Journal:  Trends Mol Med       Date:  2013-03-26       Impact factor: 11.951

4.  Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.

Authors:  David Lu; Paul A Insel
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

5.  A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes.

Authors:  Claudia Jentzsch; Simon Leierseder; Xavier Loyer; Isabell Flohrschütz; Yassine Sassi; Dorothee Hartmann; Thomas Thum; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  J Mol Cell Cardiol       Date:  2011-07-23       Impact factor: 5.000

6.  Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists.

Authors:  R Sauer; J Maurinsh; U Reith; F Fülle; K N Klotz; C E Müller
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

Review 7.  Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?

Authors:  Victoria J McIntosh; Robert D Lasley
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-02-18       Impact factor: 2.457

8.  Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes.

Authors:  Yassine Sassi; Aniella Abi-Gerges; Jeremy Fauconnier; Nathalie Mougenot; Steven Reiken; Kobra Haghighi; Evangelia G Kranias; Andrew R Marks; Alain Lacampagne; Stefan Engelhardt; Stephane N Hatem; Anne-Marie Lompre; Jean-Sébastien Hulot
Journal:  FASEB J       Date:  2011-11-16       Impact factor: 5.191

Review 9.  Basal release of ATP: an autocrine-paracrine mechanism for cell regulation.

Authors:  Ross Corriden; Paul A Insel
Journal:  Sci Signal       Date:  2010-01-12       Impact factor: 8.192

10.  Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.

Authors:  Claudia Bang; Sandor Batkai; Seema Dangwal; Shashi Kumar Gupta; Ariana Foinquinos; Angelika Holzmann; Annette Just; Janet Remke; Karina Zimmer; Andre Zeug; Evgeni Ponimaskin; Andreas Schmiedl; Xiaoke Yin; Manuel Mayr; Rashi Halder; Andre Fischer; Stefan Engelhardt; Yuanyuan Wei; Andreas Schober; Jan Fiedler; Thomas Thum
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more
  29 in total

Review 1.  In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish.

Authors:  Celinda M Kofron; Ulrike Mende
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

Review 2.  Myobolites: muscle-derived metabolites with paracrine and systemic effects.

Authors:  Ayon Ibrahim; Michael Neinast; Zoltan P Arany
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

Review 3.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

4.  Recent progress in the field of cIMP research.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-18       Impact factor: 3.000

5.  PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.

Authors:  Walter E Knight; Si Chen; Yishuai Zhang; Masayoshi Oikawa; Meiping Wu; Qian Zhou; Clint L Miller; Yujun Cai; Deanne M Mickelsen; Christine Moravec; Eric M Small; Junichi Abe; Chen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-20       Impact factor: 11.205

6.  Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.

Authors:  Yulin Li; Zhenya Li; Congcong Zhang; Ping Li; Yina Wu; Chunxiao Wang; Wayne Bond Lau; Xin-Liang Ma; Jie Du
Journal:  Circulation       Date:  2017-03-01       Impact factor: 29.690

7.  Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.

Authors:  John Fassett; Xin Xu; Dongmin Kwak; Guangshuo Zhu; Erin K Fassett; Ping Zhang; Huan Wang; Bernd Mayer; Robert J Bache; Yingjie Chen
Journal:  J Mol Cell Cardiol       Date:  2019-03-22       Impact factor: 5.000

8.  Mechanisms of Fibroblast Activation in the Remodeling Myocardium.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  Curr Pathobiol Rep       Date:  2017-04-22

9.  A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.

Authors:  Carly Jones; Malik Bisserier; Carlos Bueno-Beti; Guillaume Bonnet; Susana Neves-Zaph; Sang-Yong Lee; Javier Milara; Peter Dorfmüller; Marc Humbert; Jane A Leopold; Lahouaria Hadri; Roger J Hajjar; Yassine Sassi
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

Review 10.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.